PHARMACY

Novo Nordisk gets FDA OK for new indication for Wegovy
Wegovy is now indicated to reduce the risk of serious heart problems in overweight or obese adults.
Camber debuts generic Gralise
Camber’s generic Gralise tablets are indicated for the management of Postherpetic Neuralgia.

Lupin appoints Rakesh Bhardwaj as chief information officer

Bhardwaj will lead Lupin’s global information technology function and spearhead the company’s digital transformation.
Retail pharmacy searches for its top model

Retail pharmacy is seeking changes to the business, but what will be the ideal model?
Jeff Needham receives CHPA’s Ivan D. Combe Lifetime Achievement Award

The Ivan D. Combe Lifetime Achievement Award is the highest honor bestowed by the U.S. consumer healthcare industry.
Avenacy launches 2 new generics

Avenacy is offering two new products, Fosaprepitant for Injection, which is the generic of Emend, and Fulvestrant Injection, which is the generic of Foslodex.
CVS Health CEO Karen Lynch weighs in on health issues on CVS Evening News with Norah O’Donnell

CVS Health's Karen Lynch addressed questions on abortion pills available in store, the politics of health care and retail crime.
AAM commends Kentucky for enacting bill increasing patient biosimilar access

On March 14, Governor Andy Beshear signed Kentucky House Bill 220 into law, which allows health plans to encourage greater adoption of lower-cost biosimilar medicines.
Lupin obtains FDA OK for generic Vibramycin

Doxycycline for Injection is indicated to reduce the development of drug-resistant bacteria and maintain the effectiveness of Doxycycline and other antibacterial drugs.
Alembic intros generic Zomig

Zolmitriptan Orally Disintegrating Tablets are a serotonin receptor agonist indicated for the acute treatment of 1B/1D migraine with or without aura in adults.